UK-based Signifier Medical Technologies Ltd, which developed a daytime therapy device for sleep disordered breathing called eXcite, announced on 28 July it raised $35m in a series D financing round.
The company’s CEO Akhil Tripathi said the company will use the new funding to “bring our new therapy to millions of patients suffering from sleep disordered breathing for whom there...